138 related articles for article (PubMed ID: 27630276)
21. Focal adhesion kinase (FAK) involvement in human endometrial remodeling during the menstrual cycle.
Orazizadeh M; Rashidi I; Saremi J; Latifi M
Iran Biomed J; 2009 Apr; 13(2):95-101. PubMed ID: 19471549
[TBL] [Abstract][Full Text] [Related]
22. Effects of forkhead box C2 on carcinogenesis and lymphatic metastasis in endometrial carcinoma.
Fan YY; Deng WG; Liu YN; Li YY; Deng SL; Fu Y
Genet Mol Res; 2015 May; 14(2):5535-47. PubMed ID: 26125751
[TBL] [Abstract][Full Text] [Related]
23. Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.
Bartosch C; Lopes JM; Jerónimo C
Epigenomics; 2017 May; 9(5):737-755. PubMed ID: 28470096
[TBL] [Abstract][Full Text] [Related]
24. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
[TBL] [Abstract][Full Text] [Related]
25. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
[TBL] [Abstract][Full Text] [Related]
26. The differences in RCAS1 and DFF45 endometrial expression between late proliferative, early secretory, and mid-secretory cycle phases.
Popiela TJ; Wicherek L; Radwan M; Sikora J; Banas T; Basta P; Kulczycka M; Grabiec M; Obrzut B; Kalinka J
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S157-62. PubMed ID: 18292826
[TBL] [Abstract][Full Text] [Related]
27.
Khatami F; Shahriari S; Aminimoghaddam S; Klashami ZN; Farahani MS; Teimoori-Toolabi L; Amoli MM; Asadi M; Rashidi BH
Epigenomics; 2023 Apr; 15(8):507-516. PubMed ID: 37345350
[No Abstract] [Full Text] [Related]
28. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
Jones A; Teschendorff AE; Li Q; Hayward JD; Kannan A; Mould T; West J; Zikan M; Cibula D; Fiegl H; Lee SH; Wik E; Hadwin R; Arora R; Lemech C; Turunen H; Pakarinen P; Jacobs IJ; Salvesen HB; Bagchi MK; Bagchi IC; Widschwendter M
PLoS Med; 2013 Nov; 10(11):e1001551. PubMed ID: 24265601
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis.
Wu Y; Halverson G; Basir Z; Strawn E; Yan P; Guo SW
Am J Obstet Gynecol; 2005 Aug; 193(2):371-80. PubMed ID: 16098858
[TBL] [Abstract][Full Text] [Related]
30. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
32. Genetic regulation of methylation in human endometrium and blood and gene targets for reproductive diseases.
Mortlock S; Restuadi R; Levien R; Girling JE; Holdsworth-Carson SJ; Healey M; Zhu Z; Qi T; Wu Y; Lukowski SW; Rogers PAW; Yang J; McRae AF; Fung JN; Montgomery GW
Clin Epigenetics; 2019 Mar; 11(1):49. PubMed ID: 30871624
[TBL] [Abstract][Full Text] [Related]
33. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cells.
Ren Y; Liu X; Ma D; Feng Y; Zhong N
Cancer Genet Cytogenet; 2007 Jun; 175(2):107-16. PubMed ID: 17556066
[TBL] [Abstract][Full Text] [Related]
35. Biological age of the endometrium using DNA methylation.
Olesen MS; Starnawska A; Bybjerg-Grauholm J; Bielfeld AP; Agerholm I; Forman A; Overgaard MT; Nyegaard M
Reproduction; 2018 Feb; 155(2):167-172. PubMed ID: 29162648
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of selected genes in endometrial carcinogenesis.
Visnovsky J; Fiolka R; Kudela E; Slavik P; Krkoska M; Lasabová Z; Danko J
Neuro Endocrinol Lett; 2013; 34(7):675-80. PubMed ID: 24464006
[TBL] [Abstract][Full Text] [Related]
37. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
[TBL] [Abstract][Full Text] [Related]
38. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer.
Sasaki M; Kotcherguina L; Dharia A; Fujimoto S; Dahiya R
Cancer Res; 2001 Apr; 61(8):3262-6. PubMed ID: 11309276
[TBL] [Abstract][Full Text] [Related]
39. [A study of Bcl-2 expression in normal endometrium and endometrial carcinoma].
Zheng Y; Peng Z; Wang H
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):92-5. PubMed ID: 12205937
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
